Company Filing History:
3 out of 54 
2 out of 15,528 
2 out of 99 
Years Active: 2007-2017
Title: Pirjo Laakkonen: Innovator in Cancer Detection and Treatment
Introduction
Pirjo Laakkonen is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of brain tumors. With a total of 6 patents to her name, her work focuses on innovative methods for detecting and targeting cancer cells.
Latest Patents
Laakkonen's latest patents include groundbreaking advancements in cancer detection. One notable patent addresses the diagnosis and treatment of brain tumors by identifying cellular targets on cancer cells. This innovation allows for targeted molecular imaging to detect cancer cells in vivo. Additionally, she has developed non-invasive methods for detecting metastasized cancer cells, along with compositions and kits for use in these methods. Another significant patent involves peptides that home to tumor lymphatic vasculature. This invention provides a conjugate containing a moiety linked to a homing molecule that selectively targets tumor lymphatic vasculature, offering new methods for directing therapeutic agents to these areas.
Career Highlights
Throughout her career, Laakkonen has worked with esteemed institutions, including the University of California and the Burnham Institute for Medical Research. Her research has been pivotal in advancing the understanding of cancer biology and improving treatment options for patients.
Collaborations
Laakkonen has collaborated with notable scientists in her field, including Erkki I Ruoslahti and Kimmo Porkka. These partnerships have further enhanced her research and contributed to the development of her innovative patents.
Conclusion
Pirjo Laakkonen's work exemplifies the impact of innovation in cancer research. Her patents and collaborations continue to pave the way for advancements in the diagnosis and treatment of cancer, ultimately benefiting patients worldwide.